Search for: "AstraZeneca Pharmaceuticals, LP" Results 61 - 80 of 98
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2011, 4:06 am by Andrew Frisch
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
26 Jan 2011, 1:31 am by Ben Vernia
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
29 Dec 2010, 12:54 pm by Bexis
In a transparent attempt to hamstring pharmaceutical marketing, the state of Vermont made it illegal for data miners to sell physician prescribing information to pharmaceutical companies.  [read post]
23 Nov 2010, 1:00 am by Jason Rantanen
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
3 Nov 2010, 5:56 am by The Docket Navigator
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
3 Oct 2010, 8:57 pm by Patent Docs
Astrazeneca Pharmaceuticals LP... [read post]
30 Jul 2010, 4:06 am by Andrew Frisch
In Smith, the Third Circuit held that a pharmaceutical sales representative was not entitled to overtime pay because she qualified for the administrative exemption under the FLSA. [read post]
27 Jun 2010, 9:11 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
13 May 2010, 12:27 pm by Bexis
Astrazeneca Pharmaceuticals LP, 2009 WL 2231686 (M.D. [read post]
29 Apr 2010, 7:43 am by fraudfighters
Department Of Justice announced that it has entered into an agreement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to settle a False Claims Act lawsuit alleging that the companies submitted claims for payment to U.S. government health agencies (such as Medicare, Medicaid, and TRICARE) in connection with a scheme to illegally market the anti-psychotic drug Seroquel for uses that were not approved as safe and effective by the Food and Drug… [read post]
28 Apr 2010, 7:14 am by Mark Zamora
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
19 Mar 2010, 10:31 am by Dr. Shezad Malik
AstraZeneca Pharmaceuticals LP, MID L 1099 07 MT, Superior Court of New Jersey, Law Division, Middlesex County (New Brunswick). [read post]
10 Mar 2010, 6:05 am by John J. Cord
AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
25 Jan 2010, 5:00 am by Beck, et al.
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]